The Decline in Corporate Research: Should We Worry? | 3rd Session

The Center for Innovation Policy's conference, "The Decline in Corporate Research: Should We Worry?", was held on March 31, 2017, at Duke's "Duke in D.C." offices.

Panel 3: Perspectives from IT, Life Sciences, and Materials

Moderator: Wesley Cohen, Duke Fuqua School of Business

Panelists: Katrine Bosley, Editas Medicine
Mary Cummings, Duke Pratt School of Engineering
Steve Freilich, Du Pont Central R&D (ret.)
James McGroddy, IBM Research (ret.)
Jeff Smith, McKinsey and Co.

Government data and research point to a long decline in US corporate investment in upstream research. How pervasive is this trend across industries, technologies, and firms of different sizes? How does it compare with research spending by the federal government, universities, and companies abroad? Does it reflect less reliance on research, whoever performs it? Is it explained by capital market pressures, global competition, or other factors? Has it contributed to the slowdown in productivity growth? Are there other reasons policymakers should be concerned? If so, what policy levers should they look to—e.g., intellectual property, tax, government R&D spending, or antitrust enforcement?

This program was sponsored by a grant from the Ewing Marion Kauffman Foundation.